Viz HCM vs Eko Low Ejection Fraction Tool (ELEFT)
AI Verdict
Choose Viz HCM if…
Choose Viz HCM if your hospital or health system requires an AI-powered solution for rapid, real-time detection of suspected Hypertrophic Cardiomyopathy directly from ECGs. This tool is ideal for streamlining cardiac care coordination, automatically alerting multidisciplinary teams, and accelerating diagnosis and treatment pathways for HCM patients within an integrated hospital IT environment.
View Viz HCM →Choose Eko Low Ejection Fraction Tool (ELEFT) if…
Choose Eko Low Ejection Fraction Tool (ELEFT) if your practice, particularly in primary care or general cardiology, seeks an easy-to-use, non-invasive AI screening tool to aid in the early detection of low ejection fraction during routine physical exams. This solution is best suited for clinicians who utilize Eko digital stethoscopes and want to quickly assess heart failure risk at the point of care.
View Eko Low Ejection Fraction Tool (ELEFT) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Viz HCM | Eko Low Ejection Fraction Tool (ELEFT) |
|---|---|---|
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Low Ejection Fraction Tool (ELEFT)Eko Low Ejection Fraction Tool (ELEFT) offers a highly intuitive user experience by integrating AI directly into a familiar digital stethoscope for rapid, non-invasive screening during routine physical exams, providing results in approximately 15 seconds. Its CORE 500u00ae Digital Stethoscope, which integrates with ELEFT, received a Red Dot Design Award for its intuitive user experience and seamless integration. While Viz HCM also offers mobile alerts and EHR/PACS integration, ELEFT's direct integration into the physical exam workflow with immediate feedback provides a slight edge in point-of-care usability.
Clinical Value
Viz HCMViz HCM focuses on Hypertrophic Cardiomyopathy (HCM), a complex and often underdiagnosed condition, with claims of significantly reducing diagnosis time and extensive real-world evidence and publications. It is the first and only FDA-cleared AI algorithm for HCM detection from a standard 12-lead ECG. ELEFT provides valuable early detection of low ejection fraction, a key indicator of heart failure, for a broader patient population. However, Viz HCM's specific impact on a challenging diagnostic pathway for a serious, often missed disease gives it a slight advantage in demonstrated clinical value.
Pricing & Value
TieBoth tools have established CMS reimbursement pathways, significantly enhancing their value proposition for healthcare systems. Viz HCM's CPT codes became effective January 1, 2025, with a national payment rate of $128.90. Eko's SENSORA platform, which includes ELEFT, also received a provisional CMS reimbursement rate of $128.90 per use, effective July 2025. This parity in reimbursement and pricing structure makes them equally valuable in this dimension.
Enterprise Readiness
Viz HCMViz HCM demonstrates strong enterprise readiness with explicit claims of seamless integration into hospital IT systems, including EHR and PACS, and is trusted by over 1,700 hospitals. Viz.ai also holds comprehensive security certifications like SOC 2 Type II and multiple ISO certifications, indicating a robust and mature enterprise-level offering. While ELEFT, as part of the SENSORA platform, is also designed for enterprise use and aims to sync with EHRs, Viz.ai's broader integration claims and extensive security framework provide a more comprehensive enterprise solution.
Innovation
Eko Low Ejection Fraction Tool (ELEFT)Eko Low Ejection Fraction Tool (ELEFT) demonstrates a highly disruptive innovation by integrating AI directly into a ubiquitous medical instrument, the stethoscope, for rapid and non-invasive cardiac screening during routine physical exams. This approach reimagines a foundational tool in medicine for broad, early detection. While Viz HCM's real-time ECG analysis for HCM and care coordination is also innovative, ELEFT's transformation of the stethoscope for widespread point-of-care AI-powered diagnostics represents a slightly more accessible and foundational innovation, recognized by a Red Dot Design Award.
Support & Docs
Viz HCMViz.ai explicitly offers 24/7/365 urgent phone support, alongside a comprehensive Help Center, Customer Resources, User Guides, and Viz Academy. Eko Health also provides a Help Center with user manuals and FAQs, and options to contact sales or request a live demo. However, Viz.ai's clear commitment to round-the-clock urgent phone support indicates a more robust and readily available support system for its users.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Viz HCM | Eko Low Ejection Fraction Tool (ELEFT) |
|---|---|---|
| Tool Name | Viz HCM | Eko Low Ejection Fraction Tool (ELEFT) |
| Company | Viz.ai | Eko Health |
| Description | Viz HCM is an FDA-cleared AI tool by Viz.ai that uses real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM) and coordinate cardiac care, significantly reducing diagnosis time. | The Eko Low Ejection Fraction Tool (ELEFT) is an FDA-cleared AI algorithm that integrates with Eko digital stethoscopes to aid clinicians in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams. |
| Primary Detection Focus | Hypertrophic Cardiomyopathy (HCM) | Low Ejection Fraction (a key indicator of heart failure) |
| Key Features | AI-powered ECG analysis for HCM detection; Real-time disease detection from electrocardiograms; Mobile-based alerts and notifications to multidisciplinary care teams; Automated direction of patients to appropriate care specialists; Reduces time to diagnosis and treatment for HCM; Streamlines cardiac care coordination and clinical workflows; Seamless integration with existing clinical workflows, EHR, and PACS systems; Clinically validated with extensive real-world evidence and publications. | AI-powered low ejection fraction detection; Integrates with FDA-cleared Eko digital stethoscopes; Analyzes ECG and heart sound recordings; Provides results in approximately 15 seconds; Part of the SENSORAu2122 Cardiac Early Detection Platform; Cloud-based data processing and storage; Aids in early identification of heart failure risk; Non-invasive screening tool. |
Videos
Demos, reviews, and walkthroughs featuring Viz HCM and Eko Low Ejection Fraction Tool (ELEFT).
Frequently Asked Questions
More Comparisons
More matchups featuring Viz HCM or Eko Low Ejection Fraction Tool (ELEFT)
Backers
Who funded each tool's parent company.